跳至主要内容
临床试验/NCT01816334
NCT01816334已完成4 期

Safety and Efficacy of Nonsteroidal Antiinflammatory Drug and Glucocorticoids in Acute Sciatica

University Hospital, Grenoble2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
Mean visual analogue scale (VAS) for leg pain (radicular pain) in 3 groups

研究概览

简要总结

The purpose of this study is to determine whether anti-inflammatory drugs or glucocorticoids are effective in the treatment of acute sciatica

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • sciatica <8 weeks resistant to all treatments in ambulatory
  • Acute low back pain> 48 hours;
  • Non-deficit patients;
  • Initial VAS> 40/100;
  • Consent of patient
  • Conflict disco-radicular concordance with the clinical computed tomography scan or magnetic resonance imaging.
  • No of contraindications to methylprednisolone, ketoprofen;
  • No registration to another protocol;

排除标准

  • Pregnant, parturient, lactating mother;
  • Diabetic patient;
  • Patient with syndrome from narrowing of the lumbar vertebral canal
  • Patient with a history of lumbar surgery <1 year;
  • Patient with a Cauda equina syndrome or major motor disability;
  • Crural neuralgia
  • Patient with a deficit;
  • Suspicion of sciatica secondary, ie not conflict-related disco-root: infectious neuritis, fracture on spinal bone tumor ...
  • associated treatment or pathology contra-indicating administration methylprednisolone, ketoprofen.

研究组 & 干预措施

methylprednisolone

Active Comparator

administration of 60 mg of methylprednisolone at 8:00 am and 100 ml of 0.9 % sodium chloride (placebo) at 6:00 pm

干预措施: methylprednisolone (Drug)

methylprednisolone

Active Comparator

administration of 60 mg of methylprednisolone at 8:00 am and 100 ml of 0.9 % sodium chloride (placebo) at 6:00 pm

干预措施: Sodium Chloride (Drug)

Ketoprofen

Active Comparator

administration of 100 mg of ketoprofen at 8:00 am and at 6:00 pm

干预措施: Ketoprofen (Drug)

sodium chloride

Placebo Comparator

administration of 100 ml of 0.9% sodium chloride (placebo) at 8:00 am and at 6:00 pm

干预措施: Sodium Chloride (Drug)

结局指标

主要结局

Mean visual analogue scale (VAS) for leg pain (radicular pain) in 3 groups

时间窗: From day 0 to day 5

VAS is measured in millimiters (0 to 100). This pain score is recommended in rheumatologic units in France.

次要结局

  • Mean visual analogue scale (VAS) for back pain in 3 groups(From day 0 to day 5)
  • Assess drug compliance(From day 0 to day 5)
  • The effect of treatment on the EIFEL Questionnaire(At baseline, 1 and 3 months after intervention)
  • Improvement in Lasegue's sign compared to baseline(At baseline, Day 1,2,3,4 and 5 of study period)
  • Assess Schober's test(From Day 0 to Day 5)
  • Analgesic consumption(At baseline, day 0, 1, 2, 3, 4 and day 5, 1 and 3 months)
  • Surgery or lumbar epidural injection(At 1 and 3 months after intervention)
  • Clinical tolerance: adverse events and/or high blood pressure(at baseline, day 1, 2 3, 4 and 5)
  • Biological tolerance(at baseline, day 3 and 5)
  • Glycemic levels(at baseline, day 1 to 5)
  • Number of days of hospitalisation sick leave, number of days lost to illness(At baseline, 1 and 3 months)

研究者

发起方
University Hospital, Grenoble
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验